| |
|
|
|
OncoSec Medical Incorporated  
|
|
1.9824 -0.068 (-0.03%) |
11-22 15:29 |
|
Open: |
2.02 |
Pre close: |
2.05 |
Target:
|
2.72
|
|
High: |
2.03 |
Low: |
1.93 |
Resistance:
|
2.33
2.65
|
|
Volume: |
37,181 |
Market Cap: |
21M |
Support:
|
1.81
1.51
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
2.00
 |
MACD |
MACD(12,26):
|
-0.04  |
|
MA(20): |
2.09 |
Signal(12,26,9): |
-0.02 |
|
MA(100): |
2.10 |
Stochastic Oscillator |
%K(14,3):
|
29.69 |
|
MA(250): |
4.18 |
%D(3): |
31.25 |
|
Average Volume(K) |
3-Month: |
27465
|
52-Week |
High:
|
11.30 |
|
10-Days: |
4726 |
Low: |
1.60 |
|
RSI |
RSI(14):
|
44.30 |
Change(%): |
-78.7 |
|
Financials, Statistics and Valuation |
|
EPS |
-4.292 |
Return on Equity (ttm) |
-128.3 |
Shares Out. (M) |
10.67 |
|
EPS Est. Current Year |
-1.020 |
Return on Assets (ttm) |
-62.4 |
Shares Float (M) |
7.44 |
|
EPS Est. Next Year |
-0.820 |
PEG Ratio |
0.00 |
% Held by Insiders |
18.21 |
|
EPS Est. Next Quarter |
-0.260 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
6.40 |
|
Forward EPS |
-0.670 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
245 |
|
Book Value (p.s.) |
2.280 |
EBITDA (p.s.) |
-2.790 |
P/E |
-0.46 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
0.86 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-29.00 |
P/S |
0.00 |
|
Operating Margin |
0.00 |
Levered Free Cash Flow
(M) |
-16.86 |
P/CF |
-0.72 |
|
|
|
|
|
|
